KRAS and neoplasm: In two additional PDX models, CRC001 (KRAS G12D MT) and CRC042 (KRAS G13D MT), less pronounced effects on tumor growth inhibiton were observed with the addition of AZD0156 to chemotherapy (Supplemental Fig. 5, Additional File 1).